IRT Expertise For An Extremely Large Cardio Study
Source: Cenduit LLC
Phase IIIb Open-label Multi-Center Study for Individuals at Risk for Chronic Heart Failure. 986 sites. 48 countries. 4,000 Randomized/Enrolled patients. 35 months.
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more